New eczema ointment shows promise in phase 2 trial
Symptom relief
Completed
This study tested an ointment called RSS0393 in 168 adults with mild to moderate atopic dermatitis (eczema). The goal was to see if it safely improves skin symptoms like redness and itching. Participants applied the ointment or a placebo for a set period, and doctors measured ski…
Phase: PHASE2 • Sponsor: Reistone Biopharma Company Limited • Aim: Symptom relief
Last updated May 17, 2026 08:48 UTC